Debt Obligations - Life Sciences Narrative (Details) - USD ($)		12 Months Ended
	Jan. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Aug. 01, 2025	Mar. 05, 2025	Jul. 31, 2024
Debt Instrument [Line Items]
Accrued interest		$ 61,000,000.0	$ 17,100,000
Current portion of debt obligations		162,200,000	30,500,000
Life Sciences
Debt Instrument [Line Items]
Outstanding debt		31,900,000
Current portion of debt obligations		24,000,000.0
20.00% Notes due 2025 | Life Sciences
Debt Instrument [Line Items]
Short-term debt		$ 24,000,000.0	17,400,000
Interest rate		20.00%
20.00% Notes due 2025 | Life Sciences | Subsequent Event
Debt Instrument [Line Items]
Interest rate					20.00%
R2 Technologies | Related Party | Life Sciences
Debt Instrument [Line Items]
Face amount	$ 20,000,000
Accrued interest	$ 2,600,000		$ 2,400,000
Interest rate	20.00%		20.00%
Exit fee percentage	10.50%	11.90%
Exit fees		$ 2,200,000
Debt covenant, maturity, number of days after event	5 days
Debt covenant, proceeds received amount to cause debt maturity	$ 20,000,000
Optional prepayment, number of days written notice	5 days
Additional exit fee payable		7,900,000				$ 1,000,000
Increase in exit fee per month		1,000,000
Interest cost relating to contractual interest coupon		9,800,000	$ 2,900,000
Interest costs capitalized		4,000,000
Exit fees (non-current portion)		$ 7,900,000
Interest rate, effective percentage		57.80%	20.00%
R2 Technologies | Related Party | Life Sciences | Forecast
Debt Instrument [Line Items]
Additional exit fee payable				$ 5,000,000
R2 Technologies | Related Party | Life Sciences | Subsequent Event
Debt Instrument [Line Items]
Additional exit fee payable					$ 1,000,000
Increase in exit fee per month					$ 1,000,000
Increase in exit fee percentage					0.17%
R2 Technologies | 18.00% Note due 2023 | Related Party | Life Sciences
Debt Instrument [Line Items]
Face amount			$ 6,600,000
Accrued interest			$ 1,300,000